31 related articles for article (PubMed ID: 29874113)
1. Prognostic value of genotyping in hepatocellular carcinoma: A systematic review.
Bodard S; Liu Y; Guinebert S; Yousra K; Asselah T
J Viral Hepat; 2023 Jul; 30(7):582-587. PubMed ID: 36922710
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants in m5C modification genes are associated with survival of patients with HBV-related hepatocellular carcinoma.
Chen B; Qiu M; Gong R; Liu Y; Zhou Z; Wen Q; Wei X; Liang X; Jiang Y; Chen P; Wei Y; Huang Q; Mo Q; Lin Q; Yu H
Arch Toxicol; 2024 Apr; 98(4):1125-1134. PubMed ID: 38438738
[TBL] [Abstract][Full Text] [Related]
3. Potentially Functional Genetic Variants in the NRF2 Signaling Pathway Genes are Associated With HBV-related Hepatocellular Carcinoma Survival.
Gong R; Qiu M; Cao J; Zhou Z; Wei Y; Wen Q; Lin Q; Wei X; Liang X; Jiang Y; Chen P; Wei J; Zhan S; Liu Y; Yu H
J Cancer; 2023; 14(18):3387-3396. PubMed ID: 38021150
[TBL] [Abstract][Full Text] [Related]
4. Potential Common Molecular Mechanisms Between Periodontitis and Hepatocellular Carcinoma: A Bioinformatic Analysis and Validation.
Fan X; Song Z; Qin W; Yu T; Peng B; Shen Y
Cancer Genomics Proteomics; 2023; 20(6):602-616. PubMed ID: 37889061
[TBL] [Abstract][Full Text] [Related]
5. C18ORF54 promotes immune infiltration and poor prognosis as a potential biomarker for hepatocellular carcinoma.
Ma Y; Yan D; Tian F; Song W; Sha R; Shang X; Lv J; Maimaiti N; Kong P; Ma X
Am J Transl Res; 2023; 15(8):5007-5034. PubMed ID: 37692934
[TBL] [Abstract][Full Text] [Related]
6. Potentially functional variants of
Huang Q; Liu Y; Qiu M; Lin Q; Wei X; Zhou Z; Liang X; Li R; Chen W; Zhou X; Yu H
Front Oncol; 2022; 12():990160. PubMed ID: 36119471
[TBL] [Abstract][Full Text] [Related]
7. A Quest for New Cancer Diagnosis, Prognosis and Prediction Biomarkers and Their Use in Biosensors Development.
Ramirez-Valles EG; Rodríguez-Pulido A; Barraza-Salas M; Martínez-Velis I; Meneses-Morales I; Ayala-García VM; Alba-Fierro CA
Technol Cancer Res Treat; 2020; 19():1533033820957033. PubMed ID: 33107395
[TBL] [Abstract][Full Text] [Related]
8. Genetic Variants in DNA Mismatch Repair Pathway predict prognosis of Lung Cancer patients with receiving Platinum-Based Chemotherapy.
Liu JY; Zou T; Yin JY; Wang Z; Wang Y; Liu ZQ; Chen J; Chen ZW
J Cancer; 2020; 11(18):5281-5288. PubMed ID: 32742474
[No Abstract] [Full Text] [Related]
9. Differential expression and diagnostic significance of P53, MutS homologs 2, tropomyosin-4 in alpha-fetoprotein-negative hepatocellular carcinoma.
Gong X; Huang A
J Clin Lab Anal; 2020 Aug; 34(8):e23353. PubMed ID: 32363617
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel germline frameshift mutation p.D300fs of PMS1 in a patient with hepatocellular carcinoma: A case report and literature review.
Li X; Wu Y; Suo P; Liu G; Li L; Zhang X; Chen S; Xu M; Song L
Medicine (Baltimore); 2020 Jan; 99(5):e19076. PubMed ID: 32000458
[TBL] [Abstract][Full Text] [Related]
11. A polymorphism within the mismatch repair gene predicts prognosis and adjuvant chemotherapy benefit in gastric cancer.
Zhao X; Dai D; Li X; Shen B; Chen X; Shu Y; Wang D
Gastric Cancer; 2019 Nov; 22(6):1121-1129. PubMed ID: 30989434
[TBL] [Abstract][Full Text] [Related]
12. The MTHFR C677T mutation is not a risk factor recognized for HBV-related HCC in a population with a high prevalence of this genetic marker.
Jiao X; Luo Y; Yang B; Jing L; Li Y; Liu C; Jing X; Wang F; Wang Y; Du Z; Gao Y
Infect Genet Evol; 2017 Apr; 49():66-72. PubMed ID: 28082187
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between hepatocellular carcinoma and the interaction between hMSH2 polymorphisms and environmental factors].
Tan S; Wang W; Liu S; Wei Q; Wei J; Wang Z; Yan M; Qiu X
Zhonghua Gan Zang Bing Za Zhi; 2014 Sep; 22(9):676-9. PubMed ID: 25369252
[TBL] [Abstract][Full Text] [Related]
14. Relationship between the rs2596542 polymorphism in the MICA gene promoter and HBV/HCV infection-induced hepatocellular carcinoma: a meta-analysis.
Luo X; Wang Y; Shen A; Deng H; Ye M
BMC Med Genet; 2019 Aug; 20(1):142. PubMed ID: 31419949
[TBL] [Abstract][Full Text] [Related]
15. Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma.
Han YF; Zhao J; Ma LY; Yin JH; Chang WJ; Zhang HW; Cao GW
World J Gastroenterol; 2011 Oct; 17(38):4258-70. PubMed ID: 22090781
[TBL] [Abstract][Full Text] [Related]
16. Rs2303428 of MSH2 Is Associated with Hepatocellular Carcinoma Prognosis in a Chinese Population.
Zhu X; Wang Z; Qiu X; Wang W; Bei C; Tan C; Qin L; Ren Y; Tan S
DNA Cell Biol; 2018 Jul; 37(7):634-641. PubMed ID: 29874113
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of C-reactive protein increase susceptibility to HBV-related hepatocellular carcinoma in a Guangxi male population.
Lao X; Ren S; Lu Y; Yang D; Qin X; Li S
Int J Clin Exp Pathol; 2015; 8(12):16055-63. PubMed ID: 26884882
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
